Drug Profile
Research programme: spinal fusion therapeutics - Dong-A ST
Alternative Names: AB 204Latest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator Dong-A ST
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Musculoskeletal disorders
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for preclinical development in Musculoskeletal-disorders in South Korea (Intraspinal)